AGT’s CEO to Present at NobleCon13

Filed Under: News Releases

View: 1.27.16 Press Release – NobleCon13

View: Noble Conference – Investor Presentation

View: Webcast

More AGT News Releases

American Gene Technologies® to Present at ROTH MKM 2023 Healthcare Opportunities Conference

Addimmune, a Clinical Stage HIV-Focused Gene Therapy Company, to Go Public Through Business Combination with 10X Capital Venture Acquisition Corp. III

American Gene Technologies® Launches New Spinoff Company “Addimmune™” to Focus Exclusively on Development of HIV Cure

The Cure Chronicles, an innovative video series launched by American Gene Technologies, is the winner of the third annual BioBuzz Media Award

American Gene Technologies® Video Series “The Cure Chronicles” Wins BioBuzz Media Award

The AGT Pipeline

AGT Corporate Profile

Follow AGT on Social Media

Subscribe to Press Release and News Updates

Subscribe to our press release and published article updates to be notified when we release new content!

American Gene Technologies

6 days ago

Can genetic evidence make drugs more effective? A new study in Nature suggests YES. Drug mechanisms with genetic support have a 2.6x higher chance of success. loom.ly/NxSxjXk#genetics #science #healthcare ... See MoreSee Less

Photo

View on Facebook

American Gene Technologies

7 days ago

Dr. Marcus Conant will be participating in a roundtable on cell and #GeneTherapy alongside Andrew Dietz, MD, of @ShapeTX at this year’s CMO Summit 360 on April 18 at 12:50 PM ET. Learn more: loom.ly/EjJavXE #CMO360 ... See MoreSee Less

Photo

View on Facebook

American Gene Technologies

2 weeks ago

Exciting news for the future of medicine! The strategic market insight company Nova 1 values the cell & gene therapy market @ $18 billion in 2023 growing at a CAGR of 18% over the next decade. They see a near $100 billion market size by 2033.loom.ly/kpuPhu4#genetherapy #futureofmedicine ... See MoreSee Less

Photo

View on Facebook

American Gene Technologies

2 weeks ago

This #NYHAAD, we support NYHAAD and their mission to create meaningful and intentional spaces for young people to ask questions, learn, and talk about the impacts of HIV and their community. #StopHIVTogether #EndHIVStigma ... See MoreSee Less

Photo

View on Facebook

AGT’s CEO to Present at NobleCon13

More AGT News Releases

American Gene Technologies® to Present at ROTH MKM 2023 Healthcare Opportunities Conference

Addimmune, a Clinical Stage HIV-Focused Gene Therapy Company, to Go Public Through Business Combination with 10X Capital Venture Acquisition Corp. III

American Gene Technologies® Launches New Spinoff Company “Addimmune™” to Focus Exclusively on Development of HIV Cure

American Gene Technologies® Video Series “The Cure Chronicles” Wins BioBuzz Media Award

Follow AGT on Social Media

Subscribe to Press Release and News Updates

Get In Touch

American Gene Technologies Inc.

Contact Us

Investors

Pipeline

Technology

Media

About Us

More AGT News Releases

Follow AGT on Social Media

Subscribe to Press Release and News Updates

Get In Touch

American Gene Technologies Inc.

Contact Us

Sign-up For Our Newsletter